National and Kapodistrian University of Athens
Approaches on the acceptance criteria of dried blood spots based bioassays with the use of computational methods
Abstract
dc:descriptionDried Blood Spots (DBS) constitute a micro-sampling technique, in which a very small amount of capillary or venous blood is collected on specific, absorbent filter paper in the form of collection cards, which are then dried in room conditions. Usually, the collected blood originates from a finger or heel puncture (capillary blood), however, venous blood following a typical blood sampling may be used. The analysis is processed on a partial punch of fixed diameter (punch disk), taken from DBS via a specific puncher. Although this technique has a long history in bioanalysis, dating back centuries, the first application of DBSs for medical diagnostic purposes took place during the early 1960s, when Dr. Robert Guthrie introduced a simple test for measuring phenylalanine to detect the metabolic disorder phenylketonuria (PKU). Since that time, the utilization of DBS has been widely applied to bioanalytical assays, especially with mass spectrometric detectors, as a reliable alternative to traditional liquid biomatrices. This sampling method presents several advantages. Firstly, the technique is minimally invasive when capillary blood is used, and this fact enables DBS collection without the involvement of healthcare personnel. Sample collection and storage are easy and low cost and sample transportation is feasible without the application of specific conditions. For these reasons, DBS is nowadays widely utilized across various disciplines within life sciences and pharmaceutical research, including preclinical and clinical/pharmacokinetic trials, therapeutic drug monitoring (TDM), epidemiologic surveillance and metabolomic studies. Most importantly, this sampling approach has laid the groundwork for the initiation and expansion of neonatal screening programs globally, encompassing a wide array of biochemical and genetic analyses in this vulnerable population. Indeed, Newborn Screening (NBS) is a public health initiative conducted shortly after birth to identify specific genetic, metabolic and hormonal disorders, so-called inborn errors of metabolism (IEM). A large number of different genetic metabolic disorders exist (such as aminoacidopathies, organic acidemias, fatty acid disorders, urea circle disorders, endocrine disorders and hemoglobinopathies), varying in symptoms, treatment manifestations and disease courses. Consequently, the primary objective of NBS programs worldwide is to detect diseases early, enabling timely medical and pharmaceutical interventions to reduce morbidity and mortality during the neonatal and childhood stages. As a result, the development and expansion of NBS are regarded as key public health priorities in numerous countries. The introduction of comprehensive, population-wide NBS using tandem mass spectrometry (MS/MS) has led to broader screening panels, a significant increase in detectable disorders and the discovery of previously unrecognized diseases. Despite the many advantages associated with this alternative sampling strategy, several challenges still exist. Indeed, concerns regarding dried samples are often related to sample homogeneity, influence of the site of punching, consistency of filter paper performance and chromatographic effects. The correlation of venous and capillary blood concentrations of a given analyte is of course also of importance. However, the most debated issue is, without doubt, the so-called “hematocrit (Ht) effect’’. Ht is defined as the ratio of the volume of red blood cells to the total volume of blood. Reference interval(s) have not been defined for human Ht values, as these are dependent on several parameters, including age (neonates have higher and more variable Ht values), sex, race, nutritional status, pathological conditions (e.g. anemia, polycythemia, oncology and immunosuppressed patients) but also on other situations, such as pregnancy, smoking or residential elevation above sea level. Measured Ht values can, therefore, significantly vary between individuals and with different disease states. A different Ht leads, due to different viscosity, to different spot size, affecting assay bias. Blood viscosity is known to be impacted by Ht, which in turn affects how easily blood can spread onto DBS filter paper. As there is an increase in blood cells at high Ht levels, the blood becomes more viscous. Blood flux and diffusion characteristics on the filter paper collection device are affected due to viscosity variations, which can, therefore, have an impact on the size of the blood spots that are formed. A linear inverse relationship between DBS area and Ht value was proved following investigation of the relationship between decrease in DBS size with increasing Ht for different filter papers at a fixed volume of blood. All things considered, the Ht issue is a widely accepted pitfall in DBS analysis. The potential influence of Ht on DBS assay characteristics is well-studied, and, based on the above, it is acknowledged that, if the Ht values of the unknown blood samples vary significantly from Ht value of the calibration standards, this definitely influences assay bias; positive error for higher Ht values and negative for lower Ht values, when a punch of fixed diameter from DBS is utilized. Consequently, the increased variability in the assay performance, may sometimes, stand beyond the current applicable acceptance criteria for the total amount of bias for validated assays in regulated bioanalysis; in general, these acceptance criteria for accuracy of chromatographic assays are set at ±15% (% bias) and at ±20% for the Lower Limit of Quantification (LLOQ). Numerous factors influence how the Ht affects analyte quantitation in DBS samples, and this is mostly a problem when partial-DBS is applied. Various approaches (based on different instrumentation and techniques) have been put forth and investigated in the literature to address the Ht-dependent blood spreading on paper substrates, including the correction of quantified concentrations with a suitable correction factor (namely, an equation incorporating corrections for bias via correlation of Ht with a physical parameter), a methodology which consists of the basis for the current work.The aim of the current research undertaken within this Thesis is to introduce novel approaches on the acceptance criteria of DBS-based bioassays with the use of computational methods, in order to provide valid solutions for coping with the Ht effect in DBS analysis. As a first step in this research work, and to quantitatively assess Ht impact on the DBS measurements, a computational approach was developed and implemented in R® language. First, the % relative error was modeled with respect to Ht. Then, Monte Carlo simulations were performed in virtual adult men/women populations with different Ht levels and the % relative error in relation to the Ht used for calibrators was quantified. An upper level for % relative error being a ‘tolerable contribution’ of Ht effect to % total analytical error was finally suggested, defining, for the first time, a potential Ht range for analysis of adults’ samples, where correction of concentrations of unknown samples may be omitted. Such tolerable level for % relative error may be defined in each laboratory, also based on experimental parameters (type of paper and blood volume). As a second step of our research, a computational approach based on neonatal demographics was developed and implemented in R® language to propose a strategy using correction factors to address the Ht effect in neonatal DBS partial-spot assays. A rational “tolerance level” was also proposed for the Ht effect contribution to the total analytical error and a safe Ht range for neonatal samples, where the correction of concentrations can be omitted. Furthermore, an “alert zone” for a false positive or negative result in NBS was proposed, where the Ht effect has to be considered. As the final part of work performed for this Thesis, the correction factor approach already developed was again applied, following the utilization of an image processing algorithm developed in MATLAB® to derive a reliable equation correlating DBS areas to Ht values. The present work looks more closely at the application of image analysis to the evaluation of Ht in DBS samples. Utilizing image analysis software, DBS samples with known Ht values were processed. Preparation of cards has followed a previously developed protocol for the appropriate formation of uniform area DBSs, irrespective of Ht. The resulting areas showed close resemblance to the respective theoretical areas calculated by applying the correlation equation. Following that, the equation was utilized to determine the Ht values for each sample and a comprehensive comparison of measured versus calculated Ht was carried out, using various statistical approaches for method comparison. The results demonstrated a strong correlation, suggesting the method’s viability in estimating Ht for unknown DBS samples.Overall, this work has achieved to introduce new approaches on the acceptance criteria of DBS-based bioassays in both adult and neonate populations, using computational methodologies to investigate and address the Ht effect. It may be safely concluded that, using Ht calibration values closely representative of populations under analysis is fully rationalized, as, in this way, an acceptable level of percentage relative error can be attributed to the Ht effect leading to reduced probability for concentration corrections. Regulatory criteria for bioanalysis can, thus, be targeted, moving towards wider utilization of DBS in human pharmacokinetic and clinical trials. Also, the proposed Ht prediction methodology based on image analysis and application of a correction factor can be a valuable tool for the use of DBS analysis in real-life settings, as Ht values calculated via this approach has been proven to strongly correlate with respective measured Ht values.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ntaousani, Chrysoula
- Νταουσάνη, Χρυσούλα
Subjects
dc:subject × 24- Ξηραμένες κηλίδες αίματος
- Φαινόμενο του αιματοκρίτη
- Νεογνικός έλεγχος
- Υπολογιστική ανάλυση
- Συντελεστής διόρθωσης
- Σχετικό σφάλμα
- Dried blood spots
- Hematocrit effect
- Newborn screening
- Computational analysis
- Correction factor
- Relative error
- Χημεία
- Φυσικές Επιστήμες
- Αναλυτική χημεία
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επαγγέλματα υγείας
- Chemical Sciences
- Natural Sciences
- Analytical Chemistry
- Health Sciences
- Medical and Health Sciences
- Health Professions
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60237